» Articles » PMID: 30025105

A Perspective of AMD Through the Eyes of Immunology

Overview
Specialty Ophthalmology
Date 2018 Jul 20
PMID 30025105
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Despite strong genetic associations, compelling human histological data and numerous hypotheses generated with supportive animal data, the mechanisms of inflammation or inflammatory control of cell health during progression of age-related macular degeneration arguably remain elusive. This perspective delivers a view that maintaining tissue health requires active immune cellular and tissue pathways, but when responses are perturbed or exaggerated, chronic inflammation is destructive. There are potential pathways and processes to enable understanding and determine how potential causative factors including altered cellular metabolism, senescence, oxidative stress disrupt tissue homeostasis are engaged. Establishing differences in the immune phenotype between normal aging and AMD, and how the inter-relatedness of these triggers contribute to pathobiology is integral for future therapeutic success.

Citing Articles

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration.

Sturzbecher L, Bartolomaeus H, Bartolomaeus T, Bolz S, Sekulic A, Ueffing M Front Immunol. 2025; 16:1520188.

PMID: 39975545 PMC: 11835843. DOI: 10.3389/fimmu.2025.1520188.


Attenuated adenosine mediated immune-dampening increases natural killer cell activity in early age-related macular degeneration.

Nair A, Ghosh S, Babu V, Praveen M, Xin Y, Sahu G bioRxiv. 2025; .

PMID: 39975064 PMC: 11838234. DOI: 10.1101/2025.01.22.634301.


Associations of the Adaptive Immune System and Age-Related Macular Degeneration.

Sturzbecher L, Strauss O Adv Exp Med Biol. 2025; 1468:3-7.

PMID: 39930164 DOI: 10.1007/978-3-031-76550-6_1.


Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment.

Khan A, Chowers I, Lotery A Cells. 2023; 12(13).

PMID: 37443742 PMC: 10340338. DOI: 10.3390/cells12131708.


Complement inhibitors for age-related macular degeneration.

Tzoumas N, Riding G, Williams M, Steel D Cochrane Database Syst Rev. 2023; 6:CD009300.

PMID: 37314061 PMC: 10266126. DOI: 10.1002/14651858.CD009300.pub3.